Open AccessPregnancy Outcomes in Women Exposed to Efavirenz and Nevirapine: An Appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Côte d'Ivoire
Author(s) -
Didier Koumavi Ekouévi,
Patrick A. Coffie,
Éric Ouattara,
Raoul Moh,
Clarisse Amani-Bossé,
Eugène Messou,
Marcel Sissoko,
Xavier Anglaret,
Serge Eholié,
Christine Danel,
François Dabis
Publication year - 2011
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e3181ff04e6
Subject(s) - nevirapine , efavirenz , medicine , pregnancy , obstetrics , abortion , miscarriage , low birth weight , gynecology , viral load , human immunodeficiency virus (hiv) , antiretroviral therapy , family medicine , biology , genetics
An increasing number of HIV-infected women become pregnant while receiving efavirenz (EFV). We compared the pregnancy outcomes of women exposed to EFV and to nevirapine (NVP) during the first trimester.